Heart rate variability patterns before ventricular tachycardia onset in patients with as implantable cardioverter defibrillator

被引:78
|
作者
Lombardi, F
Porta, A
Marzegalli, M
Favale, S
Santini, M
Vincenti, A
De Rosa, A
机构
[1] Univ Milan, Osp S Paolo, Dipartimento Med Chirurg & Odontol, I-20142 Milan, Italy
[2] Osp S Carlo, Milan, Italy
[3] Policlin Bari, Bari, Italy
[4] Osp S Filippo Neri, Rome, Italy
[5] Osp S Gerardo, Monza, Italy
[6] Medtron, Milan, Italy
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 86卷 / 09期
关键词
D O I
10.1016/S0002-9149(00)01130-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Time- and frequency-domain analysis of heart rate variability (HRV) has been proven effective in describing alteration of autonomic control mechanisms and in identifying patients with increased cardiac and arrhythmic mortality. Patients with implantable cardioverter defibrillators offer the opportunity to evaluate HRV patterns before ventricular tachycardia (VT) and under control conditions. We therefore analyzed time- and frequency-domain parameters of short-term HRV and power-law behavior of RR interval time series at rest, at 15 to 30 minutes, and immediately before VT. In comparison to control conditions, lower values of mean cycle length duration and total power were observed before VT. Spectral analysis indicated that the low- to high-frequency ratio was significantly higher (5.5 +/- 0.6 vs 2.8 +/- 0.3) immediately before VT than during rest, Both findings were consistent with the shift of sympathovagal balance toward sympathetic predominance and reduced vagal tone. Before VT, a more negative value of the scaling exponent beta of the power-frequency relation (-1.57 +/- 0.04 vs -1.33 +/- 0.04) also confirmed the presence of an altered HRV pattern in comparison to controls. Thus, both abnormal autonomic modulation and dynamic patterns of HRV seem to characterize the minutes before arrhythmia onset in these patients, (C)2000 by Excerpta Medico, Inc.
引用
收藏
页码:959 / 963
页数:5
相关论文
共 50 条
  • [31] Increase in heart rate precedes episodes of ventricular tachycardia and ventricular fibrillation in patients with implantable cardioverter defibrillators: Analysis of spontaneous ventricular tachycardia database
    Nemec, J
    Hammill, SC
    Shen, WK
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (12): : 1729 - 1738
  • [32] Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review
    Farkowski, Michal Miroslaw
    Karlinski, Michal
    Pytkowski, Mariusz
    de Asmundis, Carlo
    Lewandowski, Michal
    Mugnai, Giacomo
    Conte, Giulio
    Marijon, Eloi
    Anic, Ante
    Boveda, Serge
    Providencia, Rui
    EUROPACE, 2022, : 1504 - 1511
  • [33] Heart rate variability before the onset of ventricular tachycardia:: differences between slow and fast arrhythmias
    Meyerfeldt, U
    Wessel, N
    Schütt, H
    Selbig, D
    Schumann, A
    Voss, A
    Kurths, J
    Ziehmann, C
    Dietz, R
    Schirdewan, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 84 (2-3) : 141 - 151
  • [34] Galectin-3 predicts the risk of ventricular tachycardia in ischemic heart failure patients with implantable cardioverter-defibrillator
    Grakova, E. Elena
    Kopeva, K. V.
    Teplyakov, A. Y.
    Isakov, L. K.
    Tarasov, N. I.
    Sinkova, M. N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 36 - 37
  • [35] Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator
    Gardiwal, Ajmal
    Yu, Hong
    Oswald, Hanno
    Luesebrink, Ulrich
    Ludwig, Andreas
    Pichlmaier, Andreas Maximilian
    Drexler, Helmut
    Klein, Gunnar
    EUROPACE, 2008, 10 (03): : 356 - 361
  • [36] Mood disturbance in patients with recurrent ventricular dysrhythmia before Insertion of implantable cardioverter defibrillator
    Dunbar, SB
    Jenkins, LS
    Hawthorne, M
    Porter, LS
    HEART & LUNG, 1996, 25 (04): : 253 - 261
  • [37] Safety of not using the implantable cardioverter-defibrillator in patients with haemodynamically stable sustained ventricular tachycardia
    Lau, EW
    Pathmanathan, RK
    Ng, GA
    Clune, MM
    Cooper, J
    Griffith, MJ
    CIRCULATION, 2000, 102 (18) : 524 - 524
  • [38] Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: Is device implantation justified?
    Russo, AM
    Nayak, H
    Verdino, R
    Springman, J
    Gerstenfeld, E
    Hsia, H
    Marchlinski, FE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (12): : 2289 - 2295
  • [39] Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator
    Sauer, William H.
    Zado, Erica
    Gerstenfeld, Edward P.
    Marchlinski, Francis E.
    Callans, David J.
    HEART RHYTHM, 2010, 7 (01) : 9 - 14
  • [40] Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions
    Michael Fiek
    Thomas Remp
    Martin Fleckenstein
    Tilman Pohl
    Michael Deiss
    Christopher Reithmann
    Journal of Interventional Cardiac Electrophysiology, 2015, 42 : 151 - 160